Skip to content

New paper demonstrates Adaptive’s revolutionary antibody discovery approach

Read More
Logo for Adaptive Biotechnologies
  • Investors
  • |
  • Join Our Team

Main Site Navigation

  • Immune Medicine Menu

    About

    • Immune Medicine Platform
    • The Adaptive Immune System
    • TCR Antigen Map
    • Publications

    Pharma Services

    • Research & Development Applications
    • Adaptive Immunosequencing

    Drug Discovery

    • TCR Therapeutics
    • Antibody Therapeutics
    • Target Discovery
    • Pipeline
  • MRD

    About

    • Clinical Portfolio & Pipeline
    • Publications

    Clinical Diagnostics

    • clonoSEQ
  • News and Events

    Blog

    • Immune Medicine in Action: How Adaptive Immunosequencing Helped Validate a Personalized Vaccine Trial in PDAC
    • Hope restored: The critical role that Minimal Residual Disease can play in blood cancer patient care
    • Among Multiple Myeloma Patients Receiving MRD Testing, Majority Report Meaningful Benefits
    • See all posts

    Media

    • Press Releases
    • Media Resources

    Events

    • Conferences & Events
  • Our Science

    Publications

    • Research Publications

    Credentials

    • Licenses & Accreditation

    Medical

    • Medical Affairs
    • Medical Information
    • Data & Congresses
  • About Us

    About Us

    • Who We Are
    • Our Story
    • Innovation Timeline
    • Leadership
    • Corporate Social Responsibility

    Careers

    • Career Listings

    Connect

  • Contact
  • Investors

    • Investor Relations
    • Newsroom

Blog

Read the latest stories from the Adaptive team

Recent Posts

tcr_patternbackground

Immune Medicine in Action: How Adaptive Immunosequencing Helped Validate a Personalized Vaccine Trial in PDAC

August 4, 2023

Immune Medicine in Action: How Adaptive Immunosequencing Helped Validate a Personalized Vaccine Trial in PDAC
Picture of Tiffany sitting with her dog on a couch

Hope restored: The critical role that Minimal Residual Disease can play in blood cancer patient care

March 22, 2023

Hope restored: The critical role that Minimal Residual Disease can play in blood cancer patient care
62.-Split-screenai-1920x1080-1

Among Multiple Myeloma Patients Receiving MRD Testing, Majority Report Meaningful Benefits

February 21, 2023

Among Multiple Myeloma Patients Receiving MRD Testing, Majority Report Meaningful Benefits
karen-and-dr-hashmi

A Reflection on Blood Cancer Awareness Month: Patient Spotlight

September 29, 2022

A Reflection on Blood Cancer Awareness Month: Patient Spotlight
mrd-feat

Tackling Barriers to MRD Adoption in the Community Setting

September 8, 2022

Tackling Barriers to MRD Adoption in the Community Setting
mrd-post

Clinician Attitudes are Shifting on MRD-guided Decision Making in Multiple Myeloma

August 23, 2022

Clinician Attitudes are Shifting on MRD-guided Decision Making in Multiple Myeloma
Photo of the SPIN Girls Fellows standing in front of Adaptive's Headquarters with Volunteers

SPIN Girls Field Day Retrospective

June 13, 2022

SPIN Girls Field Day Retrospective
A close up of Adaptive's Rooftop Garden

Introducing Sustainability @ Adaptive

June 1, 2022

Introducing Sustainability @ Adaptive
Image of Sydney W, former Adaptive intern, in front of a blue background

The Adaptive Internship Experience: A Perspective from Sydney W

May 18, 2022

The Adaptive Internship Experience: A Perspective from Sydney W
Adaptive Biotechnologies logo on dark blue background

A Message from Co-Founder and CEO Chad Robins

March 8, 2022

A Message from Co-Founder and CEO Chad Robins
Previous Next

While the information is considered to be true and correct at the date of publication, changes in circumstances after the time of publication may impact on the accuracy of the information. The information may change without notice and Adaptive Biotechnologies is not in any way liable for the accuracy of any information printed and stored or in any way interpreted and used by a user.

The latest from Adaptive

Press Releases

Immune Medicine

  • Immune Medicine Platform
  • The Adaptive Immune System
  • TCR Antigen Map
  • Publications

Pharma Services

  • Research & Development Applications
  • Adaptive Immunosequencing

Drug discovery

  • TCR Therapeutics
  • Antibody Therapeutics
  • Target Discovery
  • Pipeline

MRD

  • Clinical Portfolio & Pipeline
  • Publications

Clinical Diagnostics

  • clonoSEQ

News & Events

  • Press Releases
  • Media Resources
  • Blog
  • Conferences & Events

Our Science

Publications

  • Research Publications

Credentials

  • Licenses & Accreditation

Medical

  • Medical Affairs
  • Medical Information
  • Data & Congresses

About Us

  • Who We Are
  • Our Story
  • Innovation Timeline
  • Leadership
  • Investor Relations
  • Newsroom
  • Contact
  • Careers
Logo for Adaptive Biotechnologies

Diagnostics (888) 552-8988 | Corporate (206) 659-0067 | Research (855) 466-8667

CAP Accredited | College of American Pathologists
Sitemap | Privacy Policy | Cookie Policy | Notice at Collection | Do Not Sell or Share My Info (CA Residents) | Terms of Service | Code of Conduct
Facebook-f Youtube Icon-x-logo-extracted Instagram Linkedin-in

© Adaptive Biotechnologies. All Rights Reserved.